title: A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome.
authors.forename: L
authors.initials: L
authors.lastname: Shvidel
authors.forename: E
authors.initials: E
authors.lastname: Sigler
authors.forename: E
authors.initials: E
authors.lastname: Vorst
authors.forename: E
authors.initials: E
authors.lastname: Feldberg
authors.forename: N
authors.initials: N
authors.lastname: Voskoboinic
authors.forename: M
authors.initials: M
authors.lastname: Shtalrid
authors.forename: A
authors.initials: A
authors.lastname: Berrebi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002881:Chromosomes, Human, Pair 12 / Q000648:ultrastructure*; D002898:Chromosomes, Human, Pair 8 / Q000648:ultrastructure*; D003131:Combined Modality Therapy; D018450:Disease Progression; D017809:Fatal Outcome; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy / Q000235:genetics* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics*; D055728:Primary Myelofibrosis / Q000235:genetics*; D013577:Syndrome; D014178:Translocation, Genetic